Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.
about
Chronic intestinal pseudo-obstructionPharmacologic Treatment for Pediatric Gastroparesis: A Review of the LiteratureTwenty-five years of advocacy for patients with gastroparesis: support group therapy and patient reported outcome tool development.Intestinal pseudo-obstruction.Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersPostprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.Gastric function measurements in drug developmentMethods for the assessment of small-bowel and colonic transit.Prokinetics in the Management of Functional Gastrointestinal Disorders.Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adultsPerformance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants.Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders.Acute colonic pseudo-obstruction: a pharmacological approach.Measurement of Gastrointestinal and Colonic Motor Functions in Humans and AnimalsNeuroendocrine disorders of the gut.The evaluation of gastrointestinal function in diabetic patients.Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers.Intestinal pseudo-obstruction: an uncommon condition with heterogeneous etiology and unpredictable outcome.Clinical pharmacology and therapeutics.A Critical Review of the Current Clinical Landscape of Gastroparesis.
P2860
Q24647826-B09EA8AB-AAFF-49BD-8385-94B5479D1A45Q26747576-D820D617-4B93-49C4-91C3-4F2B8BC929CBQ27313265-23DA0B2F-43F7-46FF-A974-C4B8213918CDQ34081809-AE3452B7-D3AF-45D7-9538-4FAC1B2CCEDCQ34166903-36DF59A8-7057-48C7-8F57-909E40316FC9Q34377869-0D7CAB5B-CF1B-412B-83E6-46853E37E124Q35190650-BE782880-C797-4C70-9E8D-50042DAC4C36Q35724278-2D87D76D-E6DD-4949-AD14-BF9EA24940B0Q35834499-666A2BB3-0DA4-4117-9E66-6BA83770CE33Q35841296-C154D9E6-204B-4282-9ADF-A52581E8E7E9Q36301151-0CBFA99E-32B7-4D9A-8BF0-1B28832EB903Q36319562-415EE24B-51E2-4485-9195-6D52F3CB0B57Q36813897-DC99995F-D9E8-4F93-8F7B-D507291BE97DQ37261844-B3F4D16F-9E1A-45CD-AA0E-A057EB38FC55Q40245760-83BB7FBB-1E8B-452D-8667-5BF699F82484Q41515150-24C766D8-6D49-4D4F-8489-4EF0853EC66CQ42721572-D3665576-D42E-4694-A6AB-E32475E723A8Q42749229-DC437A30-645A-42B6-9DB5-EFCCC9530502Q43263960-72901ADE-B5D7-4026-BEA7-C59495D56C31Q55234456-5CCC9D78-C135-44CF-BCB5-5772B5B9720F
P2860
Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Effect of six weeks of treatme ...... intestinal pseudoobstruction.
@en
Effect of six weeks of treatme ...... intestinal pseudoobstruction.
@nl
type
label
Effect of six weeks of treatme ...... intestinal pseudoobstruction.
@en
Effect of six weeks of treatme ...... intestinal pseudoobstruction.
@nl
prefLabel
Effect of six weeks of treatme ...... intestinal pseudoobstruction.
@en
Effect of six weeks of treatme ...... intestinal pseudoobstruction.
@nl
P2093
P1433
P1476
Effect of six weeks of treatme ...... d intestinal pseudoobstruction
@en
P2093
A R Zinsmeister
J R Malagelada
M Camilleri
P304
P356
10.1016/0016-5085(89)90893-7
P407
P577
1989-03-01T00:00:00Z